Vilar-Ribó, Laura http://orcid.org/0000-0001-8758-523X
Cabana-Domínguez, Judit http://orcid.org/0000-0002-4732-7284
Martorell, Lourdes http://orcid.org/0000-0003-4999-2197
Ramos-Quiroga, Josep Antoni
Sanchez-Roige, Sandra http://orcid.org/0000-0001-6137-5699
Palmer, Abraham A.
Vilella, Elisabet http://orcid.org/0000-0002-1887-5919
Ribasés, Marta http://orcid.org/0000-0003-1039-1116
Muntané, Gerard http://orcid.org/0000-0003-1541-8365
Soler Artigas, María http://orcid.org/0000-0002-3213-1107
Article History
Received: 31 May 2022
Revised: 3 February 2023
Accepted: 20 February 2023
First Online: 11 March 2023
Competing interests
: JARQ was on the speakers bureau and/or acted as consultant for Janssen-Cilag, Novartis, Shire, Takeda, Bial, Shionogi, Sincrolab, Novartis, BMS, Medice, Technofarma, Rubió and Raffo in the last 3 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire, Takeda, Shionogi, Bial and Medice. The Department of Psychiatry Mental Health chaired by him received unrestricted educational and research support from the following companies in the last 3 years: Janssen- Cilag, Shire, Oryzon, Roche, Psious, and Rubió. AAP is on the scientific advisory board, owns stock options and a patent (ExternalRef removed) for Vivid Genomics (ExternalRef removed). All other authors declare no competing interests.